Skip to main content
Caplight Logo









Gordian Pharma Ltd.

Gordian Pharma Ltd.

Private
OxfordHealthcare & Life Scienceshttps://gordianpharma.com/

Last Round

Grant

Aug 6, 2025

Total Funding Raised

$510,000

Company Overview

Gordian Pharma Ltd. is a biotechnology company that develops localized therapies for patients with high-unmet-need cancers, specifically focusing on glioblastoma.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyglioblastoma treatmentdrug developmentoncologyhydrogel therapeuticclinical trialssolid tumor treatmentlocalized therapyneuro-oncologypreclinical researchdrug discoverybiotech startupcancer researchtherapeutic pipelinedrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gordian Pharma Ltd. Comparables

Compare Gordian Pharma Ltd. with similar companies based on industry and business-model similarity.

Gordian Pharma Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TargTex
91%
Double Bond Pharmaceutical International AB
84%
IntraGel Therapeutics
80%

Gordian Pharma Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 6, 2025
SeedMar 18, 2022

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 6, 2025

    $510K raised from The Brain Tumour Charity.

  • Mar 18, 2022

    $4M raised in Seed round.

Gordian Pharma Ltd. Filings

Explore SEC and related filing metadata, where available.

Gordian Pharma Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Gordian Pharma Ltd.'s valuation, stock price, and market status.

Is Gordian Pharma Ltd. a public or private company?

Gordian Pharma Ltd. is a private company.

What is the current stock price of Gordian Pharma Ltd.?

Gordian Pharma Ltd. is a private company with no public stock price. Caplight tracks Gordian Pharma Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Gordian Pharma Ltd. worth (valuation)?

Valuation information for Gordian Pharma Ltd. is not publicly available.

Can I buy Gordian Pharma Ltd. stock?

Gordian Pharma Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Gordian Pharma Ltd.'s last funding round?

Gordian Pharma Ltd.'s most recent funding round was Grant on August 6, 2025.

Who are the main investors in Gordian Pharma Ltd.?

Investor information for Gordian Pharma Ltd. is not publicly disclosed.

Will Gordian Pharma Ltd. IPO soon?

No public IPO plans have been announced for Gordian Pharma Ltd..

How can I track Gordian Pharma Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gordian Pharma Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOxford
Year Founded2020
Last FundingAug 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?